Bank of New York Mellon Corp - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 59 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 2.54 and the average weighting 0.7%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$14,000
-33.3%
27,1820.0%0.00%
Q2 2020$21,000
-88.0%
27,182
-84.1%
0.00%
Q1 2020$175,000
-29.7%
171,434
+6.7%
0.00%
Q4 2019$249,000
-16.2%
160,626
-2.3%
0.00%
Q3 2019$297,000
+21.2%
164,378
+9.7%
0.00%
Q2 2019$245,000
+198.8%
149,870
+225.7%
0.00%
Q1 2019$82,000
-15.5%
46,013
-10.7%
0.00%
Q4 2018$97,000
-5.8%
51,501
+78.5%
0.00%
Q3 2018$103,000
+71.7%
28,8560.0%0.00%
Q2 2018$60,00028,8560.00%
Other shareholders

There were no reported owners of EYEPOINT PHARMACEUTICALS INC in Q2 2019.

NameSharesValueWeighting ↓
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders